A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

Phase 1 Completed 71 enrolled Sandoz

RandomizedParallel-groupOpen-labelOther

Summary

This study will evaluate bioequivalence of two formulations of Ferric Carboxymaltose as measured by serum total iron, in adult patients with iron deficiency anemia.

Timeline

Start: 2017-11-29
Primary completion: 2019-01-15
Completion: 2019-01-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ferric carboxymaltose	Other / unclassified	750 mg	Intravenous

A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

Summary

Timeline

Drugs

Indications